Together, our results confirm the role of the LCE3B-LCE3C deletion in psoriasis and support the presence of genetic risk mechanisms for AD within the EDC in addition to the predominant effect of FLG-null mutations, with opposing effects on psoriasis. The gene discussed is LCE3B; the disease is psoriasis.